Free Trial

Erste Group Bank Comments on OTCMKTS:MURGY FY2026 Earnings

M�nchener R�ckversicherungs-Gesellschaft logo with Finance background
Image from MarketBeat Media, LLC.

Key Points

  • Erste Group Bank slightly lowered its FY2026 EPS estimate for Munich Re’s ADR to $5.88 from $5.89, while keeping a Strong-Buy rating. It also projected FY2027 EPS of $6.26.
  • Munich Re’s stock was trading near the bottom of its 52-week range, opening at $11.81 versus a high of $14.41. The company carries a low valuation profile, with a P/E of 6.67 and a beta of 0.46.
  • The company’s most recent quarterly results were in line with expectations, reporting $0.17 EPS and revenue of $19.77 billion, slightly above consensus. Munich Re also showed solid profitability with a 19.10% return on equity.
  • MarketBeat previews the top five stocks to own by June 1st.

M�nchener R�ckversicherungs-Gesellschaft (OTCMKTS:MURGY - Free Report) - Analysts at Erste Group Bank dropped their FY2026 EPS estimates for shares of M�nchener R�ckversicherungs-Gesellschaft in a report released on Tuesday, May 5th. Erste Group Bank analyst S. Lingnau now expects that the financial services provider will post earnings of $5.88 per share for the year, down from their prior estimate of $5.89. Erste Group Bank currently has a "Strong-Buy" rating on the stock. The consensus estimate for M�nchener R�ckversicherungs-Gesellschaft's current full-year earnings is $4.37 per share. Erste Group Bank also issued estimates for M�nchener R�ckversicherungs-Gesellschaft's FY2027 earnings at $6.26 EPS.

A number of other analysts also recently commented on MURGY. Kepler Capital Markets initiated coverage on shares of M�nchener R�ckversicherungs-Gesellschaft in a research report on Friday, January 16th. They set a "buy" rating on the stock. Zacks Research upgraded shares of M�nchener R�ckversicherungs-Gesellschaft from a "hold" rating to a "strong-buy" rating in a research report on Wednesday, April 29th. Two analysts have rated the stock with a Strong Buy rating and one has given a Buy rating to the company's stock. According to data from MarketBeat, M�nchener R�ckversicherungs-Gesellschaft has an average rating of "Strong Buy".

Read Our Latest Research Report on MURGY

M�nchener R�ckversicherungs-Gesellschaft Price Performance

MURGY stock opened at $11.81 on Monday. M�nchener R�ckversicherungs-Gesellschaft has a 52 week low of $11.75 and a 52 week high of $14.41. The company has a market capitalization of $75.56 billion, a price-to-earnings ratio of 6.67, a price-to-earnings-growth ratio of 0.47 and a beta of 0.46. The firm's 50-day moving average is $12.61 and its two-hundred day moving average is $12.60. The company has a current ratio of 1.14, a quick ratio of 1.14 and a debt-to-equity ratio of 0.22.

M�nchener R�ckversicherungs-Gesellschaft (OTCMKTS:MURGY - Get Free Report) last released its quarterly earnings results on Thursday, February 26th. The financial services provider reported $0.17 EPS for the quarter, hitting analysts' consensus estimates of $0.17. M�nchener R�ckversicherungs-Gesellschaft had a net margin of 10.19% and a return on equity of 19.10%. The company had revenue of $19.77 billion for the quarter, compared to the consensus estimate of $19.51 billion.

About M�nchener R�ckversicherungs-Gesellschaft

(Get Free Report)

Münchener Rückversicherungs-Gesellschaft OTCMKTS: MURGY, commonly known as Munich Re, is a global reinsurance company headquartered in Munich, Germany. The firm's core business is providing reinsurance solutions to primary insurers, covering property–casualty and life & health risks. Munich Re also offers specialty reinsurance products for complex or large-scale exposures and develops tailored risk-transfer solutions for clients facing catastrophic, industrial, or longevity risks.

In addition to its reinsurance operations, Munich Re conducts primary insurance activities through its ERGO Group subsidiary, which markets life, health, property & casualty, and legal protection insurance to retail and corporate customers.

Read More

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in M�nchener R�ckversicherungs-Gesellschaft Right Now?

Before you consider M�nchener R�ckversicherungs-Gesellschaft, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and M�nchener R�ckversicherungs-Gesellschaft wasn't on the list.

While M�nchener R�ckversicherungs-Gesellschaft currently has a Strong Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for May 2026. Learn which stocks have the most short interest and how to trade them. Click the link to see which companies made the list.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines